| Financial Year |
March 31 2023 |
| Monetary Funds |
311,618,920.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
162,791,889.94 |
| Advances to Suppliers |
11,825,370.96 |
| Other Receivables |
6,795,219.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
119,206,370.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
104,181,000.00 |
| Other Current Assets |
252,839,012.66 |
| Total Current Assets |
970,900,978.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,800,000.00 |
| Long-term Equity Investment |
92,675.53 |
| Investment Properties |
-- |
| Fixed Assetes |
752,756,359.86 |
| Under-construction Projects |
563,349,618.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
216,843,244.68 |
| R&D expenses |
-- |
| Goodwill |
57,477,638.86 |
| Long-Term Deferred and Prepaid Expenses |
7,641,708.14 |
| Deferred Income Tax Assets |
18,379,211.10 |
| Other Non-Current Assets |
19,895,134.97 |
| Sub-Total of Non-Current Assets |
1,662,180,723.18 |
| Total Assets |
2,633,081,701.86 |
| Short-Term Loans |
147,087,005.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,755,000.00 |
| Accounts Payable |
150,606,921.28 |
| Accounts Received In Advance |
8,562.69 |
| Employee Compensation Payable |
15,696,144.18 |
| Taxes Payable |
11,018,266.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,307,184.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,874,293.83 |
| Other Current Liabilities |
3,975,231.85 |
| Sub-Total of Current Liabilities |
465,173,438.66 |
| Long-term Loans |
316,808,589.80 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,679,637.29 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,982,701.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
349,140,709.45 |
| Total Liabilities |
814,314,148.11 |
| Paid-In Capital(Or Share Stock) |
537,237,415.00 |
| Capital Surplus |
678,991,036.94 |
| Surplus Reserve |
37,369,257.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
489,127,552.32 |
| Minority Stockholder's Interest |
77,281,620.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,741,485,932.78 |
| Owner's Equity（Stockholder's Equity） |
1,818,767,553.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,633,081,701.86 |
